Abstract: Two simple and sensitive extractive spectrophotometric methods have been described for the assay of Lansoprazole (LPZ) either in pure form or in pharmaceutical formulations. The methods were based on the formation of ion-pair complex between LPZ and Metanil Yellow (MY) -Method-A and methyl orange (MO)-Method-B, at pH 2.5 has been described. The formed complex were extracted quantitatively into chloroform and measured at 440 nm and 450 nm with MY and MO respectively. Beer's law was obeyed in the concentration range of 20-70 µg mL -1 and 6-16 µg mL -1 with molar absorptivity of 1.329 x 10 -8 and 1.822 x 10 -8 L mol -1 cm -1 with MY and MO respectively. Statistical comparison of the results of the proposed method with those of the reference method shows excellent agreement and indicates no significant difference in accuracy and precision. The limits of detection and quantification have been determined for two methods. Both the methods have been validated as per the guidelines of ICH. The methods have been applied to the determination of drug in commercial capsules and results of analysis were validated statistically through recovery studies
Introduction

Lansoprazole (RS)-2-([3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl sulfinyl)-1H-benzo[d] imidazol (
) is a substituted benzimidazole compound and it is a proton pump inhibitor 1 , widely used as an antiulcer drug in the treatment and maintenance of healing of duodenal or gastric ulcers, erosive and reflux esophagitis. It is official in USP, The characteristic properties of LPZ are due to its secondary and tertiary amino groups and sulphoxide grouping 2 .
Figure 1. Chemical structure of Lansoprazole
RESEARCH ARTICLE
LPZ has a greater inhibitory effect on H. pylori than omeprazole, and is thus widely used in the treatment of benign gastric ulcer associated with H. pylori; duodenal ulcer and reflux oesophagatis. LPZ is also indicated for Zollinger-Ellison Syndrome and acid related Dyspepsia. The therapeutic importance of LPZ justifies research to develop analytical methods for its determination in body fluids and in pharmaceuticals.
Because of simplicity, reasonable accuracy and precision, speed and sensitivity, visible spectrophotometry has withstood the test of time and remained competitive with the newer analytical methods. Literature survey revealed that the only visible spectrophotometric method 3 reported is based on the formation of a blue chromogen measurable at 810 nm when LPZ was reacted with iron(III) chloride and ferricyanide in HCl medium. Few more methods such as HPLC [4] [5] [6] , HPTLC 7 , LC-MS-MS 8,9, Tirimetric 10-12, UV spectrophotometry 13, 14 and visible spectrophotometry 15 , relatively little attention was paid to the development of visible spectrophotometric methods for this drug.
The present investigation aims to develop sensitive and cost-effective methods for the determination of LPZ in pure form and in tablet dosage form by extractive visible spectrophotometry. The methods utilize Metanil Yellow (MY) -Method-A and Methyl Orange (MO)-Method-B as reagents. The methods have the advantages of speed and simplicity besides being accurate and precise, and can be adopted by the pharmaceutical laboratories for industrial quality control.
Experimental
Instrument
Electronic Weighing balance -(Single pan balance, Model Axis LC/GC), Digital pH meter (Model-Systronics), Sonicator-Ultra Sonicator (Model-Bandelin sonorex), Double beam UV-Visible spectrophotometer -Schimadzu 1800. UV spectra of standard and sample solutions were recorded in 1cm quartz cells at the wavelength ranges of 200-400 nm.
Chemicals and Reagents
Lansoprazole (LPZ) was obtained as a gift sample from Hetero drugs Pvt. Ltd, Hyderabad, India. Metanil yellow (MY) and methyl orange (MO) was purchased from Merck, Mumbai. Chloroform, potassium dihydrogen phosphate was purchased from SD Fine chem, Mumbai. Distilled water was prepared in house. All other chemicals used were AR grade.
Preparations of Buffer and Reagents
Preparation of phosphate buffer of pH 2.5 100 g of potassium dihydrogen phosphate was dissolved in 800 mL of water; pH of the resulting solution was adjusted to 2.5 with dilute hydrochloric acid. The final volume was made to 1000 mL with distilled water.
Preparation of standard stock solution
A standard stock solution of LPZ was prepared by dissolving 100 mg of it in methanol in a 100 mL volumetric flask, the final volume was made upto the mark with the same to get the final concentration of 1 mg/mL.
Preparation of working standard solution
A working standard solution containing 100 µg/mL was prepared by diluting the above stock solution. The fresh working standards were prepared dialy.
Determination of λ max
Method A: with metanil yellow (MY)
In a 25 mL separating funnel, 1 mL of working standard of the drug was taken, 2 mL phosphate buffer pH 2.5, 5 mL of chloroform and 2 mL of 0.4 % MY was added, stirred vigorously, and the chloroform layer was separated carefully. A light orange colored complex was observed. The resulted solution was scanned for the determination of λ max in the visible range of 400-800 nm.
Method B: With methyl orange (MO)
In a 25 mL separating funnel, 1 mL of working standard of the drug was taken, 2 mL phosphate buffer pH 2.5, 5 mL of chloroform and 2 mL of 0.2 % MO was added, stirred vigorously, and the chloroform layer was separated carefully. A light yellow colored complex was observed. The resulted solution was scanned for the determination of λ max in the visible range of 400-800 nm.
Preparation of sample solution (for assay of lansoprazole capsules)
Lansoprazole (PREVACID novartis), containing 15 mg were successfully analyzed by the proposed methods. 10 capsules of Prevacid were accurately weighed and powdered. Tablet powder equivalent to 100 mg of LPZ was dissolved in 100 mL of ethanol in a 100 mL volumetric flask and filtered. The solution was suitably diluted and analysed employing the procedures given under the procedure for bulk samples. None of the excipients usually employed in the formulation of capsules interfered in the analysis of LPZ by the proposed methods. A summary of results of both the methods were shown in Table 1 . 
Results and Discussions
Method A (with MY)
LPZ was found to react with MY under the experimental conditions to form a light orange colored complex exhibiting λ max at 440 nm. The λ max curve was shown in Figure 2 .
Method B (with MO)
LPZ was found to react with MO under the experimental conditions to form Light yellow colored complex, exhibiting λ max at 450 nm. The λ max curve was shown in Figure 3 . 
LOD and LOQ
The limit of detection (LOD) is defined as the minimum level at which the analyte can be reliably detected for the two methods was calculated using the following equation LOD= 3.3 X Standard deviation / Slope In accordance with the formula, the detection limits were found to be 0.903 and 0.254 µg/mL for method A and B, respectively. The limit of quantification (LOQ) is defined as the lowest concentration that can be measured with acceptable accuracy and precision LOQ=10 X Standard deviation / Slope According to this equation, the limit of quantification was found to be 2.738 and 0.77 µg/mL for Method A and B respectively; the summary of validation parameters for the two methods is given in Table 1 .
Accuracy and precision
The accuracy and precision of the proposed method were determined at three concentration levels of LPZ (within the linear range) by analyzing three replicate analyses on pure drug of each concentration. The percentage relative error as accuracy and percentage relative standard deviations (RSD) as precision for the results did not exceed 2% for the two methods as shown in Table 1 , indicating the good reproducibility and repeatability of the two methods. This good level of precision and accuracy was suitable for quality control analysis of LPZ in their pharmaceutical formulation.
Application of the methods
The proposed methods were applied to the pharmaceutical formulation containing LPZ. The results are shown in Table 1 indicate the high accuracy of the proposed methods for the determination of the studied drug. The proposed methods have the advantage of being virtually free from interferences by excipients. The mean percentage purities were 100.06 ± 0.24 and 100.00 ± 0.26 for method A and B, respectively (Table 1) .
Conclusion
The development visible spectrophotometric methods for the determination of LPZ in pharmaceutical formulation were simple, sensitive, rapid and accurate. These methods were practical and valuable for routine application in quality control laboratories for analysis of LPZ. Concentration, mg/mL Absorbance
